WeVote
Log In

Bill

Bill

A 2937

Requires health insurers, SHBP, and SEHBP to provide coverage for certain drug regimens for treatment of AIDS or HIV under certain circumstances.

2024-2025 Regular Session Introduced by Gary Schaer

New Jersey bill mandates health insurers cover specified HIV/AIDS drug treatments, removing cost barriers to antiretroviral therapy but leaving coverage scope and conditions undefined.

Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
#disease #healthinsur
0
WeVote Research Nonpartisan
Bill Summary · A 2937

Legislative bill overview

Bill A 2937 requires health insurers, the State Health Benefits Plan (SHBP), and School Employees Health Benefits Plan (SEHBP) in New Jersey to cover specific drug regimens for HIV/AIDS treatment under defined circumstances. The bill establishes mandated coverage requirements for antiretroviral therapies without specifying which particular drugs or regimens qualify as "certain drug regimens."

Why is this important

HIV/AIDS treatment has evolved dramatically, with modern antiretroviral therapy enabling people with HIV to achieve undetectable viral loads and near-normal lifespans. Ensuring insurance coverage removes financial barriers to these life-saving medications. However, the bill's vague language about which regimens qualify creates implementation uncertainty and potential coverage disputes between patients and insurers.

Potential points of contention

  • Undefined scope: The bill references "certain drug regimens" without specifying which medications or treatment protocols are covered, leaving interpretation to regulators and potentially creating inconsistent coverage
  • Cost implications: Mandated HIV/AIDS drug coverage increases insurer costs, which may be passed to employers (via SHBP/SEHBP) and individual policyholders through higher premiums
  • "Certain circumstances" ambiguity: The unspecified conditions triggering coverage requirements could lead to disputes about when insurers must provide benefits and potential denials based on different interpretations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.